Open original FDA record ↗Recall record
- FDA identifier
- Z-0313-2019
- Company in FDA record
- Becton Dickinson & Co.
- FDA record creation date
- Oct 31, 2018
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
A trend for false positive Candida glabrata results has been confirmed. The discrepant results impact the Candida glabrata target only, when in the presence of a Trichomonas vaginalis true positive.
Source facts
- Action
- Urgent Medical Device Product Recall notification letters dated 9/24/18 were sent to customers.
- Initiated
- 2018-09-24
- Root cause
- Nonconforming Material/Component
- Terminated
- 2020-04-10
- Distribution
- Worldwide distribution - US nationwide in the states of AL, AZ, CA, CO, DC, FL, GA, IL, IN, KY, LA, MD, MI, MO, NC, NJ, NM, NY, OH, OR, PA, SC, TN, TX, UT, VA, WA, WI, and Puerto Rico. Countries of Spain, Germany, France, Austria, Denmark, Switzerland, Sweden, Italy, Kuwait, Oman, Saudi Arabia, and Turkey.
- Recall number
- Z-0313-2019
- Recall status
- Terminated
- CDRH record ID
- 167568
- FDA record created
- 2018-10-31
- Recall event number
- 81145